Table 4.
Fetuses with skeleton anomalies after maternal exposure to Ni+2 (as NiCl2·6H2O).
| Parameters (%) | Group I (control) |
Group II (46.125 mg Ni/kg b.wt.) |
Group III (92.25 mg Ni/kg b.wt.) |
Group IV (184.5 mg Ni/kg b.wt.) |
|---|---|---|---|---|
| Total fetuses with different skeletal anomalies | 0 | 22.7 | 35.0 | 50.0 |
| Skull | 0 | 18.1 | 25.0 | 40.6 |
| Vertebral column | 0 | 0 | 5.0 | 9.3 |
| Ribs | 0 | 4.5 | 5.0 | 6.2 |
| Sternum | 0 | 9.0 | 15.0 | 18.7 |
| Pelvic elements | 0 | 0 | 5.0 | 6.2 |
| Caudal vertebrae | 0 | 0 | 5.0 | 6.2 |
| Carpals, metacarpals, tarsals, metatarsals, and phalanges | 0 | 18.1 | 25.0 | 46.8 |